| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
27,371 | 19,742 | 11,022 | - | - | - | - | - | - | - |
Gross profit | |||||||||
- | - | 6,746 | 4,778 | 3,814 | 3,035 | 3,762 | 2,292 | 1,403 | 856 |
Costs and operating expenses: | |||||||||
Product sales | |||||||||
- | - | - | 8,226 | 6,448 | 6,190 | 8,340 | 5,642 | 2,738 | 2,061 |
Licensing revenue | |||||||||
- | - | - | - | - | - | 609 | 20 | 20 | 20 |
Total revenue | |||||||||
- | - | - | - | - | - | 8,949 | 5,662 | 2,758 | 2,081 |
Cost of product and rental revenue (exclusive of intangible assets amortization) | |||||||||
8,760 | 6,217 | 4,276 | 3,448 | 2,634 | 3,155 | 5,186 | 3,370 | 1,355 | 1,225 |
Research and development | |||||||||
3,168 | 1,298 | 1,193 | 2,028 | 1,378 | 871 | 487 | 463 | 516 | 318 |
Sales and marketing | |||||||||
4,701 | 2,615 | 2,086 | 3,009 | 2,583 | 1,329 | 841 | 619 | 267 | 431 |
General and administrative | |||||||||
8,893 | 5,950 | 4,523 | 4,592 | 4,868 | 3,970 | 2,718 | 2,151 | 1,829 | 1,500 |
Amortization of intangible assets | |||||||||
1,079 | - | - | - | - | - | - | - | - | - |
Acquisition costs | |||||||||
940 | - | - | - | - | - | - | - | - | - |
Change in fair value of contingent consideration | |||||||||
50 | - | - | - | - | - | - | - | - | - |
Total operating expenses | |||||||||
27,591 | 16,080 | - | - | - | - | - | - | - | - |
Total operating expenses | |||||||||
- | - | 7,802 | 9,630 | 8,831 | 6,171 | 4,048 | 3,234 | 2,612 | 2,250 |
Operating income (loss) | |||||||||
-220 | 3,662 | -1,056 | -4,851 | -5,017 | -3,135 | -285 | -942 | -1,209 | -1,394 |
Other income (expenses) | |||||||||
Change in fair value of warrant liability | |||||||||
12,835 | 28,271 | - | - | - | - | - | - | - | - |
Interest income | |||||||||
- | - | 1 | 2 | 21 | 20 | 0 | 94 | 0 | - |
Interest income | |||||||||
506 | 281 | - | - | - | - | - | - | - | 0 |
Interest expense | |||||||||
5 | 5 | 190 | 100 | - | 177 | 742 | 733 | 670 | 588 |
Other expenses | |||||||||
13 | - | - | - | - | - | - | - | - | - |
Financing costs and write off of deferred financing costs | |||||||||
- | - | 109 | - | - | - | - | - | - | - |
Write-off of deferred financing costs | |||||||||
- | - | - | 86 | - | - | - | - | - | - |
Write off of deferred financing costs | |||||||||
- | - | - | - | 0 | 13 | 56 | 78 | 74 | 0 |
Amortization of debt discount | |||||||||
- | - | 156 | 218 | 0 | - | - | - | - | - |
Loss on disposal of property and equipment | |||||||||
- | - | - | -1 | 0 | - | - | - | - | -1 |
Loss on Disposal of Assets | |||||||||
- | - | - | - | - | 4 | 0 | 0 | - | - |
Interest expense, related party | |||||||||
- | - | - | - | 0 | - | - | - | - | - |
Loss on deconsolidation of biologistex | |||||||||
- | - | - | -2,785 | 0 | - | - | - | - | - |
Loss from equity-method investment in SAVSU | |||||||||
-739 | -672 | -1,005 | 0 | - | - | - | - | - | - |
Gain on acquisition of SAVSU | |||||||||
10,108 | - | - | - | - | - | - | - | - | - |
Loss on disposal of property and equipment | |||||||||
- | - | - | - | - | - | - | - | -1 | - |
Total other expenses | |||||||||
-2,978 | -28,667 | -1,459 | -3,189 | 21 | -165 | -798 | -717 | -746 | -589 |
Net loss before provision for income taxes | |||||||||
-3,198 | -25,005 | -2,515 | - | - | - | - | - | - | - |
Income tax (benefit) | |||||||||
-1,541 | - | - | - | - | - | - | - | - | - |
Net Loss | |||||||||
- | - | - | -8,041 | -4,995 | -3,300 | -1,084 | - | - | - |
Net Loss attributable to non-controlling interest | |||||||||
- | - | - | -1,165 | -781 | -83 | 0 | - | - | - |
Net loss | |||||||||
-1,657 | -25,005 | -2,515 | -6,875 | -4,213 | -3,217 | -1,084 | -1,659 | -1,956 | -1,983 |
Less: Preferred stock dividends and accumulated deficit impact of preferred stock redemption | |||||||||
- | 339 | 213 | 0 | - | - | - | - | - | - |
Net income (loss) attributable to common stockholders | |||||||||
-1,657 | -25,344 | -2,728 | -6,875 | - | - | - | - | - | - |
Basic net income per common share (in dollars per share) | |||||||||
- | - | -0.21 | - | - | - | - | - | - | - |
Diluted net income per common share (in dollars per share) | |||||||||
- | - | -0.21 | - | - | - | - | - | - | - |
Basic shares used to compute earnings per share (in shares) | |||||||||
- | - | 13,263 | - | - | - | - | - | - | - |
Basic and Diluted (in dollars per share) | |||||||||
-0.09 | -1.56 | - | -0.54 | -0.35 | -0.31 | -0.22 | -0.33 | -0.03 | -0.03 |
Basic and Diluted (in shares) | |||||||||
19,460 | 16,256 | - | 12,642 | 12,177 | 10,447 | 5,007 | - | - | - |
Basic and diluted weighted average common shares used to calculate net loss per common share | |||||||||
- | - | - | - | - | - | - | 4,977 | - | 69,679 |
Diluted shares used to compute earnings per share (in shares) | |||||||||
- | - | 13,263 | - | - | - | - | - | 69,679 | - |
Product [Member] | |||||||||
Revenue | |||||||||
26,844 | 19,742 | - | - | - | - | - | - | - | - |
Rental Revenue [Member] | |||||||||
Revenue | |||||||||
527 | - | - | - | - | - | - | - | - | - |